Claret Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$226K Sell
579
-28
-5% -$11.8K 0.02% 366
2026
Q1
$287K Hold
607
0.03% 198
2025
Q4
$283K Buy
607
+2
+0.3% +$929 0.03% 200
2025
Q3
$258K Sell
605
-9
-1% -$3.49K 0.03% 232
2025
Q2
$235K Buy
+614
New +$221K 0.03% 245
2025
Q1
Hold
0
282
2024
Q4
Sell
-576
Closed -$234K 323
2024
Q3
$234K Buy
+576
New +$211K 0.04% 197

Other funds holding HCA

Claret Asset Management's HCA Position: Q2 2026 in Review

Claret Asset Management reduced its HCA Healthcare (HCA) stake by 4.6% in Q2 2026, selling an estimated $11.8K and leaving 579 shares worth $226K. The position accounts for 0.02% of the portfolio, ranked #366.

Claret Asset Management first reported a position in HCA in Q3 2024 and has held it in 6 quarters since. The position peaked at $287K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • Claret Asset Management held 579 shares of HCA Healthcare worth $226K as of Q2 2026.
  • Claret Asset Management sold 28 HCA Healthcare shares in Q2 2026, an estimated $11.8K.
  • HCA Healthcare made up 0.02% of Claret Asset Management's portfolio in Q2 2026, its #366 holding.
  • Claret Asset Management first reported a position in HCA Healthcare in Q3 2024 and has held it in 6 quarters since.
  • Claret Asset Management's HCA Healthcare position peaked at $287K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on Claret Asset Management's 13F filing for Q2 2026, filed 27 Jul 2026.